---
title: "Mahamaya Lifesciences Ltd (MAHALIFE) — Share Price, Financials & Analysis"
symbol: "544611"
company: "Mahamaya Lifesciences Ltd"
canonical: "https://tapetide.com/stocks/544611"
isin: "INE0U9D01019"
bse_code: "544611"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 424.01
generated_at: "2026-10-15T11:37:28.985Z"
---

# Mahamaya Lifesciences Ltd (MAHALIFE)

Canonical page: https://tapetide.com/stocks/544611

## Company

- **BSE Code:** 544611
- **ISIN:** INE0U9D01019
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2025-11-18
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** mahamayalifesciences.com/home

## About

ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]

## Latest Price

- **Price:** ₹181.15
- **Change:** -5.85 (-3.13%)
- **Open:** ₹184.05
- **Day High:** ₹187
- **Day Low:** ₹179.3
- **Previous Close:** ₹187
- **Volume:** 112800
- **As Of:** 2026-10-15T11:00:57+00:00

## Key Fundamentals

Price-based figures as of 2026-10-15T16:30:57+05:30.

Observed at 2026-10-15T04:48:03.863401Z.

- **Market Cap:** ₹424.01 Cr
- **Classification:** SME
- **P/E (TTM):** 60.38
- **EPS (TTM):** ₹3
- **Book Value:** ₹52.1
- **Price to Book:** 3.48
- **Dividend Yield:** 0%
- **ROE:** 13.55%
- **ROCE:** 25.18%
- **Debt to Equity:** 0.75
- **Revenue (yearly):** ₹330 Cr
- **Net Income:** ₹16.5 Cr
- **EBITDA:** ₹34.3 Cr
- **52-Week High:** ₹205.05
- **52-Week Low:** ₹111
- **RSI (14):** 58

## Tapetide Score

- **Score:** 36 / 100
- **Score date:** 2026-10-14
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 7.1 (of 4490 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 40.07 | 9% |
| growth | 67.06 | 9% |
| momentum | 67.46 | 12% |
| ownership | 23.46 | 24% |
| quality | 31.95 | 22% |
| valuation | 18.13 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | -30.79% | — |
| ebitda margin growth | 9.9% | 6.9% | 16.5% | 48.29% |
| net income growth | 5.4% | 28.91% | 64% | 511.11% |
| revenue growth | 118.4% | 23.5% | 34% | 29.62% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 146 | 163 | 166 |
| Expenses | 133 | 148 | 149 |
| Operating Profit | 13 | 15 | 17 |
| OPM % | 9 | 9 | 10 |
| Other Income | 1 | 1 | 1 |
| Interest | 4 | 4 | 4 |
| Depreciation | 1 | 1 | 1 |
| Profit before tax | 10 | 11 | 12 |
| Tax % | 27 | 27 | 35 |
| Net Profit | 7 | 8 | 8 |
| EPS in Rs | 4.08 | 4.71 | 3.48 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 90 | 137 | 161 | 266 | 329 |
| Expenses | 84 | 128 | 148 | 241 | 296 |
| Operating Profit | 6 | 9 | 13 | 25 | 34 |
| OPM % | 7 | 6 | 8 | 9 | 10 |
| Other Income | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 3 | 6 | 7 | 8 |
| Depreciation | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 4 | 5 | 7 | 17 | 24 |
| Tax % | 27 | 26 | 27 | 26 | 31 |
| Net Profit | 3 | 4 | 5 | 13 | 17 |
| EPS in Rs | 21.78 | 30.03 | 41.8 | 7.21 | 7.06 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 1 | 18 | 23 |
| Reserves | 14 | 18 | 23 | 32 | 99 |
| Borrowings | 19 | 24 | 55 | 58 | 91 |
| Other Liabilities | 21 | 34 | 33 | 81 | 98 |
| Total Liabilities | 56 | 78 | 112 | 188 | 310 |
| Fixed Assets | 20 | 21 | 21 | 27 | 35 |
| CWIP | 2 | 2 | 3 | 4 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 54 | 88 | 157 | 267 |
| Total Assets | 56 | 78 | 112 | 188 | 310 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | 1 | -23 | 0 | -30 |
| Cash from Investing Activity | -3 | -3 | -2 | -7 | -16 |
| Cash from Financing Activity | 1 | 2 | 24 | 9 | 81 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 35 |
| Free Cash Flow | -1 | -2 | -25 | -5 | -38 |
| CFO/OP | 56 | 24 | -162 | 6 | -75 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 37 | 25 | 64 | 67 | 78 |
| Inventory Days | 93 | 109 | 137 | 167 | 194 |
| Days Payable | 83 | 87 | 61 | 92 | 88 |
| Cash Conversion Cycle | 47 | 48 | 140 | 142 | 184 |
| Working Capital Days | 8 | 9 | 14 | 29 | 49 |
| ROCE % | — | 20 | 21 | 26 | 20 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2026 |
| --- | --- |
| Promoters | 56.35% |
| FIIs | 4.77% |
| DIIs | 2.52% |
| Government | 0% |
| Public | 10.65% |
| Others | 25.71% |
| No. of Shareholders | 584 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 178.56 | Buy |
| EMA (10) | 179.66 | Buy |
| SMA (20) | 179.84 | Buy |
| EMA (20) | 179.84 | Buy |
| SMA (50) | 182.31 | Buy |
| EMA (50) | 179.56 | Buy |
| SMA (100) | 175.67 | Buy |
| EMA (100) | 177.21 | Buy |
| SMA (200) | 175.29 | Buy |
| EMA (200) | 171.78 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 57.62 | Neutral |
| MACD (12,26,9) | -0.4 | Buy |
| Stochastic (14,3,3) | 47.68 | Neutral |
| ADX (14) | 16.29 | Neutral |
| Williams %R (14) | -12.5 | Sell |
| ATR (14) | 7.04 | High Volatility |
| ROC (12) | 2.19 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 44.6 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-05-05 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/xml-data/corpfiling/AttachLive/11bebf2d-6fdc-4ae5-b8b6-69b3d1362a19.pdf) |
| 2026-05-04 | [Intimation Under Regulation 30 (LODR)_Certificate Of Appreciation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbee9b5f-28fa-4a43-9037-1dbb8b171c78.pdf) |
| 2026-05-04 | [Intimation Under Regulation 30 (LODR)_Certificate Of Appreciation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fbee9b5f-28fa-4a43-9037-1dbb8b171c78.pdf) |
| 2026-04-28 | [Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b8bc8b9-7b98-479b-b1d1-0300fd696ed6.pdf) |
| 2026-04-28 | [Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b8bc8b9-7b98-479b-b1d1-0300fd696ed6.pdf) |
| 2026-04-15 | [Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a33c7ac-2bf4-4956-a3ea-60a3fe082ee6.pdf) |
| 2026-04-04 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18c13531-e1ee-4d17-b195-a586e9c038cf.pdf) |
| 2026-04-03 | [Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f8caa053-d722-49ea-bc3f-d7f3b91bf8c9.pdf) |
| 2026-03-30 | [Closure of Trading Window](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c554ac4-7867-487b-b045-2561682e4b28.pdf) |
| 2026-03-10 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Utilisation Of Unutilised IPO Proceeds In Subsequent Fiscal Years.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0da3db9-b577-479a-b27c-0fd72ffd0eae.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport//5329080316.pdf) |
| 2015 | [Financial Year 2015](https://www.bseindia.com/bseplus/AnnualReport//5329080615.pdf) |
| 2014 | [Financial Year 2014](https://www.bseindia.com/bseplus/AnnualReport//5329080614.pdf) |
| 2013 | [Financial Year 2013](https://www.bseindia.com/bseplus/AnnualReport//5329080613.pdf) |
| 2012 | [Financial Year 2012](https://www.bseindia.com/bseplus/AnnualReport//5329080612.pdf) |
| 2012 | [Financial Year 2012](https://archives.nseindia.com/annual_reports/AR_2561_SHARONBIO_2011_2012_21102013140012.zip) |
| 2010 | [Financial Year 2010](https://www.bseindia.com/bseplus/AnnualReport//5329080610.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2020-12-08 | Credit rating update — CARE Ratings |
| 2020-06-24 | Credit rating update — CARE Ratings |
| 2019-03-27 | Credit rating update — CARE Ratings |
| 2018-01-08 | Credit rating update — CARE Ratings |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07790eb8-8fd8-4006-bef9-ababc770a625.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-10-09 | [Publication Of Executive Interview In Agropages Magazine (2026 India Focus Issue)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b95b7d8-b85b-4c6c-8c2a-519edcd97cad.pdf) |
| 2026-10-08 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7b53eb4-a1dc-4919-a1f3-054ab45bb745.pdf) |
| 2026-09-30 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4858bb45-3638-4553-ab14-a59e96b8ef72.pdf) |
| 2026-09-30 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b848292a-57ed-4feb-8034-51b78f470a19.pdf) |
| 2026-09-29 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a9739f-6e12-4193-8c27-c75e8f31192f.pdf) |
| 2026-09-28 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40b1a173-8fed-483d-b727-fa3c4b6ba467.pdf) |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dc1ba03-2dc1-4584-9a9d-0fd3bfd86643.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8605abd4-d7c7-4ee8-b843-61c6c0ebe95a.pdf) |
| 2026-09-07 | [Notice Of 24Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2f33efd-e9ee-4b38-a946-653e8f3992f7.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=504e8168-d56b-48c0-8663-2ca2f425de73.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-25 | [The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e92fb1e-ed49-4b33-b6aa-5d4fe45ec094.pdf) |
| 2025-12-02 | [Submission Of Half Yearly Financial Results - September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cb34c8c-baf4-4848-9800-a770f590a70e.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-15T11:37:28.985Z.